Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
SC45647 is a synthetic guanidine-based sweetener that elicits a sweet taste in both humans and rodents. It is used primarily as an experimental tool in research on the molecular mechanisms of sweet taste perception. SC45647 acts as an agonist of the human sweet taste receptor, specifically targeting the T1R2 + T1R3 heterodimer, which belongs to the class C G protein-coupled receptors (GPCRs). The compound has been utilized as a positive control in studies investigating ligand binding and activation mechanisms of these receptors. Structurally, it belongs to the class of organic compounds known as phenylmethylamines[1][2][5]. There are no known therapeutic or commercial uses for this compound outside laboratory research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on SC45647.